Annette W. Fothergill

Author

The University of Texas Health Science Center at San Antonio

Also Known As

A Fothergill, A W Fothergill, A. Fothergill, A. W. FOTHERGILL, A. W. Fothergill, A.W Fothergill, A.W. Fothergill, Annette Fothergill, Annette W Fothergill, Annette W. Fothergill

214

Publications

12.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio South Texas Veterans Health Care System Murphy Oil Corporation (United States)Universitat Rovira i Virgili Institut d'Investigació Sanitària Pere Virgili

About

Annette W. Fothergill is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	68	5.2K
2	Health Sciences	26	30	2.5K
3	Natural Sciences	4	4	678
4	Public Health	2	2	282
5	Engineering	1	1	83

Annette W. Fothergill

126

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within the<i>Fusarium solani</i>Species Complex Kerry O’Donnell, Deanna A. Sutton, Annette W. Fothergill, Journal of Clinical Microbiology Diagnostic MycologyGeneticsPlant PathologyGenomicsPlant-pathogen Interaction	2008	460
In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes Qiu N. Sun, Annette W. Fothergill, Dora I. McCarthy, Antimicrobial Agents and Chemotherapy	2002	364
In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents Nikolaos G. Almyroudis, Deanna A. Sutton, Annette W. Fothergill, Antimicrobial Agents and Chemotherapy Antifungal AgentHealth SciencesFungal PathogenAntifungal AgentsVitro Susceptibilities	2007	283
In Vitro Amphotericin B Resistance in Clinical Isolates of <i>Aspergillus terreus</i> , with a Head-to-Head Comparison to Voriconazole Deanna A. Sutton, Stephen Sanche, Sanjay G. Revankar, Journal of Clinical Microbiology	1999	251
Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole Ana Espinel‐Ingroff, Ana Isabel Aller, Laura Rosío Castañón-Olivares, Antimicrobial Agents and Chemotherapy Diagnostic MycologyPathogenic MicrobiologyPathogen DetectionClinical MycologyClsi Mics	2012	246
Spectrum of Clinically Relevant<i>Exophiala</i>Species in the United States Jianhua Zeng, Deanna A. Sutton, Annette W. Fothergill, Journal of Clinical Microbiology	2007	233
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six <i>Aspergillus</i> spp. for the CLSI Broth Microdilution Method (M38-A2 Document) Ana Espinel-Ingroff, Daniel J. Diekema, Annette W. Fothergill, Journal of Clinical Microbiology Diagnostic MycologyAntifungal AgentHealth SciencesFungal PathogenAntifungal Agents	2010	232
Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for <i>Aspergillus</i> spp.: NCCLS Collaborative Study Ana Espinel‐Ingroff, Annette W. Fothergill, J. Peter, Journal of Clinical Microbiology	2002	193
In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of <i>Aspergillus</i> spp Sofía Perea, Gloria M. González, Annette W. Fothergill, Antimicrobial Agents and Chemotherapy	2002	187
Detection of <i>Candida dubliniensis</i> in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates William R. Kirkpatrick, Sanjay G. Revankar, Robert K. McAtee, Journal of Clinical Microbiology	1998	187

Page 1